Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model

Parkinson’s disease (PD) is the second most common neurodegenerative disease. Treatment of PD is challenging, as current treatment strategies are only symptomatic and do not stop disease development. Recent studies reported neuroprotective effects of calcitriol in PD through its antioxidant and anti...

Full description

Bibliographic Details
Main Authors: Alshimaa Magdy, Eman A. E. Farrag, Shereen Mohamed Hamed, Zienab Abdallah, Eman Mohamad El Nashar, Mansour Abdullah Alghamdi, Amira A. H. Ali, Marwa Abd El-kader
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2022.967813/full
_version_ 1811261524362133504
author Alshimaa Magdy
Eman A. E. Farrag
Shereen Mohamed Hamed
Zienab Abdallah
Eman Mohamad El Nashar
Eman Mohamad El Nashar
Mansour Abdullah Alghamdi
Mansour Abdullah Alghamdi
Amira A. H. Ali
Amira A. H. Ali
Marwa Abd El-kader
author_facet Alshimaa Magdy
Eman A. E. Farrag
Shereen Mohamed Hamed
Zienab Abdallah
Eman Mohamad El Nashar
Eman Mohamad El Nashar
Mansour Abdullah Alghamdi
Mansour Abdullah Alghamdi
Amira A. H. Ali
Amira A. H. Ali
Marwa Abd El-kader
author_sort Alshimaa Magdy
collection DOAJ
description Parkinson’s disease (PD) is the second most common neurodegenerative disease. Treatment of PD is challenging, as current treatment strategies are only symptomatic and do not stop disease development. Recent studies reported neuroprotective effects of calcitriol in PD through its antioxidant and anti-inflammatory properties. The exact pathomechanisms of PD are not yet fully understood. So, investigation of different molecular pathways is challenging. Sirtuin-1 (Sirt1) modulates multiple physiological processes, including programmed cell death, DNA repair, and inflammation. Furthermore, defective autophagy is considered a key pathomechanism in PD as it eliminates protein aggregation and dysfunctional cell organelles. The present study investigated the involvement of autophagy and Sirt1/NF-κB molecular pathway in rotenone-induced PD and explored the protective and restorative effects of calcitriol through these mechanisms. Therefore, behavioral tests were used to test the effect of calcitriol on motor disability and equilibrium. Furthermore, the histological and neuronal architecture was assessed. The expression of genes encoding neuroinflammation and autophagy markers was determined by qPCR while their protein levels were determined by Western blot analysis and immune-histochemical staining. Our results indicate that behavioral impairments and dopaminergic neuron depletion in the rotenone-induced PD model were improved by calcitriol administration. Furthermore, calcitriol attenuated rotenone-induced neuroinflammation and autophagy dysfunction in PD rats through up-regulation of Sirt1 and LC3 and down-regulation of P62 and NF-κB expression levels. Thus, calcitriol could induce a neuro-protective and restorative effect in the rotenone-induced PD model by modulating autophagy and Sirt1/NF-κB pathway.
first_indexed 2024-04-12T19:05:32Z
format Article
id doaj.art-d8a316202f3e4b33a843189d4cfd60da
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-04-12T19:05:32Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-d8a316202f3e4b33a843189d4cfd60da2022-12-22T03:20:02ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022022-09-011610.3389/fncel.2022.967813967813Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat modelAlshimaa Magdy0Eman A. E. Farrag1Shereen Mohamed Hamed2Zienab Abdallah3Eman Mohamad El Nashar4Eman Mohamad El Nashar5Mansour Abdullah Alghamdi6Mansour Abdullah Alghamdi7Amira A. H. Ali8Amira A. H. Ali9Marwa Abd El-kader10Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura, EgyptDepartment of Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, EgyptDepartment of Medical Histology, Faculty of Medicine, Mansoura University, Mansoura, EgyptDepartment of Medical Physiology, Faculty of Medicine, Mansoura University, Mansoura, EgyptDepartment of Anatomy, College of Medicine, King Khalid University, Abha, Saudi ArabiaDepartment of Histology and Cell Biology, Faculty of Medicine, Benha University, Benha, EgyptDepartment of Anatomy, College of Medicine, King Khalid University, Abha, Saudi ArabiaGenomics and Personalized Medicine Unit, College of Medicine, King Khalid University, Abha, Saudi ArabiaDepartment of Human Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura, EgyptInstitute of Anatomy ll, Medical Faculty, Heinrich Heine University, Düsseldorf, GermanyDepartment of Human Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura, EgyptParkinson’s disease (PD) is the second most common neurodegenerative disease. Treatment of PD is challenging, as current treatment strategies are only symptomatic and do not stop disease development. Recent studies reported neuroprotective effects of calcitriol in PD through its antioxidant and anti-inflammatory properties. The exact pathomechanisms of PD are not yet fully understood. So, investigation of different molecular pathways is challenging. Sirtuin-1 (Sirt1) modulates multiple physiological processes, including programmed cell death, DNA repair, and inflammation. Furthermore, defective autophagy is considered a key pathomechanism in PD as it eliminates protein aggregation and dysfunctional cell organelles. The present study investigated the involvement of autophagy and Sirt1/NF-κB molecular pathway in rotenone-induced PD and explored the protective and restorative effects of calcitriol through these mechanisms. Therefore, behavioral tests were used to test the effect of calcitriol on motor disability and equilibrium. Furthermore, the histological and neuronal architecture was assessed. The expression of genes encoding neuroinflammation and autophagy markers was determined by qPCR while their protein levels were determined by Western blot analysis and immune-histochemical staining. Our results indicate that behavioral impairments and dopaminergic neuron depletion in the rotenone-induced PD model were improved by calcitriol administration. Furthermore, calcitriol attenuated rotenone-induced neuroinflammation and autophagy dysfunction in PD rats through up-regulation of Sirt1 and LC3 and down-regulation of P62 and NF-κB expression levels. Thus, calcitriol could induce a neuro-protective and restorative effect in the rotenone-induced PD model by modulating autophagy and Sirt1/NF-κB pathway.https://www.frontiersin.org/articles/10.3389/fncel.2022.967813/fullrotenoneParkinson’sSirt1NF-kBautophagyvitamin D
spellingShingle Alshimaa Magdy
Eman A. E. Farrag
Shereen Mohamed Hamed
Zienab Abdallah
Eman Mohamad El Nashar
Eman Mohamad El Nashar
Mansour Abdullah Alghamdi
Mansour Abdullah Alghamdi
Amira A. H. Ali
Amira A. H. Ali
Marwa Abd El-kader
Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
Frontiers in Cellular Neuroscience
rotenone
Parkinson’s
Sirt1
NF-kB
autophagy
vitamin D
title Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
title_full Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
title_fullStr Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
title_full_unstemmed Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
title_short Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
title_sort neuroprotective and therapeutic effects of calcitriol in rotenone induced parkinson s disease rat model
topic rotenone
Parkinson’s
Sirt1
NF-kB
autophagy
vitamin D
url https://www.frontiersin.org/articles/10.3389/fncel.2022.967813/full
work_keys_str_mv AT alshimaamagdy neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT emanaefarrag neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT shereenmohamedhamed neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT zienababdallah neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT emanmohamadelnashar neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT emanmohamadelnashar neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT mansourabdullahalghamdi neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT mansourabdullahalghamdi neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT amiraahali neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT amiraahali neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel
AT marwaabdelkader neuroprotectiveandtherapeuticeffectsofcalcitriolinrotenoneinducedparkinsonsdiseaseratmodel